by Jessica Casebolt | May 17, 2024 | Life Sciences, Tea Leaves
The U.S. Justice Department on Thursday unveiled a historic proposal to ease restrictions on marijuana, a rule that, if enacted, would also enable more research on its medicinal benefits. The proposal, first announced in April, would reclassify cannabis from a...
by Jessica Casebolt | Mar 11, 2024 | Life Sciences, Tea Leaves
Federal health officials have proposed reclassification of marijuana after determining that it poses a lower public health risk than other controlled substances and offers possible medical benefits. The extensive scientific review illuminates the rationale...
by Jessica Casebolt | Mar 11, 2024 | Life Sciences, Tea Leaves
The U.S. Food and Drug Administration (FDA) said it has seized “thousands of units” of counterfeit Ozempic, the diabetes drug widely used for weight loss, that had been distributed through legitimate drug supply sources. The FDA and the drug’s maker, Novo Nordisk, are...
by Jessica Casebolt | Sep 11, 2023 | Life Sciences, Tea Leaves
CVS Health said on Wednesday that it has launched a new company called Cordavis that will work directly with manufacturers to commercialize and co-produce biosimilar medicines for the U.S. market. CVS will initially work with the manufacturer Sandoz to produce a...
by Jessica Casebolt | Sep 11, 2023 | Life Sciences, Tea Leaves
According to research published Wednesday, gender-affirming surgeries dipped in 2020 after nearly tripling in the years leading up to the pandemic. The study, published in JAMA Network Open, found that the number of gender-affirming procedures performed in the U.S....
by Jessica Casebolt | Sep 11, 2023 | Life Sciences, Tea Leaves
The Biden administration on Tuesday announced the first funding awards from its $5 billion project aimed at developing the next generation of COVID-19 vaccines and treatments. The project is intended to support vaccines that are longer lasting and more protective...
Recent Comments